Page 138 - Read Online
P. 138

Page 6                     Spiliopoulou  et al. Cancer Drug Resist 2024;7:2  https://dx.doi.org/10.20517/cdr.2023.46



































                Figure 3. General Concept of Developing Drugs Blocking Activity of T  cells: In general, there are three main compartments enriched in
                                                             reg
                T  cells, which are currently being targeted with drugs: (1) Extracellularly by blocking Ligands (white background), such as IL-2.
                reg
                Alternatively, blocking specific receptors on T  cells, e.g., CTLA-4, CCR4, with monoclonal antibodies, such as ipilimumab or
                                                reg
                mogamulizumab, can arrest the activity of T  cells; (2) Intracellularly (red background), signaling pathways can be blocked with small
                                             reg
                molecule inhibitors, e.g., targeting PI3K-δ; (3) Transcription, gene modification is targeted with different pharmacological agents, such
                as antisense oligonucleotides, molecular glue, and small molecules. These pharmacological interventions are mainly in non-clinical or
                early clinical investigations. They target a variety of factors, of which HELIOS and FOXP3 are perhaps the most unique to T  cells.
                                                                                                    reg
                T  cells: T regulatory cells; IL: interleukin; CTLA-4: cytotoxic T lymphocyte antigen-4; CCR4: C-C chemokine receptor; PI3K-δ:
                reg
                phosphoinositide-3-kinase delta; FOXP3: forkhead box protein P3.
               In addition to intracellular transcription factors and the interaction with TCR, chemokines such as C-C
               motif chemokine ligand (CCL22) can induce the formation of T  cells . CCL22, secreted by dendritic cells
                                                                          [46]
                                                                     reg
               (DC) and macrophages, engages with its receptor C-C chemokine receptor (CCR4), which is predominantly
               expressed on T  cells . Blocking this CCL22/CCR4 axis and consequently removing T  cells leads to anti-
                                 [47]
                                                                                         reg
                            reg
               tumor immune responses . Recent studies further show that FOXP3 is required to increase the expression
                                     [48]
               of CCR4 on T  cells . This co-regulation underscores that soluble and molecular events determine the fate
                                [49]
                           reg
               of T  cells.
                   reg
               Epiregulation
               The function or the generation of T  cells can also be influenced by mechanisms of epiregulation . In
                                                                                                     [50]
                                               reg
               murine models, complement factors determined the methylation of the FOXP3 in T  cells. Since
                                                                                              reg
               complement is part of the innate immune system, epigenetic regulation of T  cells appears to occur early
                                                                                 reg
               during an immune response. Hence, interventions of blocking complement activation may have an impact
               on the generation of T  cells.
                                  reg
               Immunosuppressive function of T  cells
                                              reg
               The classifications of T  cells can be based on functional studies for all T  cells or their subsets. Generally,
                                                                             reg
                                   reg
               T  cells exert their suppressive function in three ways: (1) soluble factors; (2) inhibitory receptors; (3)
                reg
                                                     [51]
               competition for activation or growth factors . In recent years, the list of such mechanisms has expanded,
               and the following examples for each mechanism are presented to illustrate the basis for novel anti-cancer
   133   134   135   136   137   138   139   140   141   142   143